Reitox National Focal Point National Bureau for Drug Prevention

Slides:



Advertisements
Similar presentations
Daliah Heller, PhD, MPH Assistant Commissioner
Advertisements

Meeting need and improving coverage workshop. Meeting need: calculating and improving coverage.
IMPACT report - SANANIM Bratislava; October 17,
IMPACT report - SANANIM Prague; February 21,
Saving lives, changing minds. Collaborative TB/HIV services for people who use drugs The experience of Red Cross / Red Crescent Lasha Goguadze.
MDM Harm Reduction (needle exchange) program in Kabul-Afghanistan.
Hepatitis C Action Plan Prevention Working Group Findings and recommendations Norah Palmateer Health Protection Scotland Greater Glasgow & Clyde MCN June.
GAP Report 2014 Prisoners People left behind: Prisoners Link with the pdf, Prisoners.
HIV and Hepatitis C in non- MSM Rural Communities: Issues and Interventions Shari Wells-Weiss, CASAC Director of Prevention Services Southern Tier AIDS.
“Humanitarian Action” The Saint-Petersburg Charitable Foundation for Medical and Social Programs HAF.
Slide 5.1 Topic 5. Supporting programs aimed at reducing the spread of HIV among and from IDU Needle and Syringe Programs Opioid Substitution Treatment.
Sex work among people who inject drugs in England, Wales & Northern Ireland: Findings from a National Survey of Health Harms and Behaviours Sara Croxford,
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
Drug use, related problems and interventions targeting drug users in prison in the European countries: main issues and challenges for the future Linda.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
HIV and drug prevention in Estonia Harm reduction services
WORK PACKAGE TREATMENT CHALLENGES Dr.Thomas Legl Member of Executive Committee EURO –TC Director Kur- und Gesundheitszentrum Knappenhof/Austria ICAA,,
Harm Reduction.
Recommendations on the Management of Opioid Overdose Ruth Birgin.
Annual report 2010: the state of the drugs problem in Europe.
TI for IDUs Sexual IDUBlood Perinatal Unidentified Routes of HIV Transmission SENTINEL SURVEILLANCE 2006 HIV infection in India.
Essential package of targeted interventions for MARA Romania Experience.
The British vs. American Models in history Drug addiction is illness Drug addiction is illness Medical model: based on controlled dispensation of drugs.
Washington D.C., USA, July 2012www.aids2012.org Human rights as a key component of harm reduction strategy targeting people using drugs in Morocco.
DEMOCRACY, CITIES AND DRUGS II Thematic Platforms Presentation Young wanderers and drugs Presentation ANIT is the French federation of health centres and.
HARM REDUCTION Bogotá November 2008 The Czech Republic in the heart of Europe.
EU model – evidence based Out of 100% of people who tried drugs, only 10% get to chronicle stage Out of 100% of people who tried drugs, only 10% get to.
„ Roma and Drugs in Figures – the Czech Republic“ Budapest, October 2004 Czech National Focal Point for Drugs and Drug Addiction Office of the Government.
Harm Reduction International
Keeping up with the epidemic Programme success leaves us with new challenges: An evaluation of programmes for injecting sex workers.
Knowing your Epidemic: Designing Better Interventions in Prisons Deputy Commissioner Mary C. Chepkonga Kenya Prisons Service International AIDS Conference.
Harm Reduction Team Maureen Woods Team Leader. Service Delivery Aims Develop harm reduction initiatives in partnership with other agencies to reduce the.
BEST PRACTICE PORTAL BEST PRACTICE PORTAL project presentation to the Scientific Committee Ferri et al Lisbon, 16th July 2010.
Substance Misuse Treatment Framework – Needle Exchange Implications for planning and practice Carry Burton North Wales Needle Syringe Programme & Harm.
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
19 June 2007 Prison & Health Expert Meeting Paris Drugs and prisons DG SANCO C4 N. GRENIER.
Organizing Drug Users for Public Health Policy Changes 17 th International Conference on the Reduction of Drug Related Harm Jason Farrell, Executive Director.
Current state of HIV and associated infections epidemic among adolescents and youth: LATVIA Anda Karnite, MPH, PHD Riga Stradins University and Baltic.
Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Riga, 29 May 2008 Sintija Šmite, UNODC.
Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network.
Presented by Nathalie Rose Social Worker PILS (Prevention Information Lutte contre le Sida) 5 August, 2008 IAC.
Outline Introduction: Harm reduction in Global Fund programs
NEW PSYCHOACTIVE SUBSTANCES (NPS) AND HARM REDUCTION
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
Northern Dimension HIV/AIDS Group meeting Tallin, April 2008
High HIV prevalence among drug injecting female sex workers in Viet Nam: The need to reduce both sexual and injection risks in this vulnerable population.
Needle Exchange Update
Pakistan Last updated: July 2015.
Sherry Deren, Sung-Yeon Kang, Milton Mino & Honoria Guarino
Addressing Drug Use Together Through a Health Based Approach:
Harm Reduction 24/7: The supply of harm reduction materials via vending machines for drug users in North Rhine-Westphalia, Germany. Prof. Dr. Daniel.
Hepatitis C Testing, Care and Treatment at Harm Reduction Centres in the European Union: a 28-Country Survey of Service Providers Prof Jeffrey V Lazarus.
The Rise and Fall of Harm Reduction in Hungary
People who inject drugs
Access to Services in Prison and Beyond
Medication use and misuse among illicit drug users in France Lisbon Addictions 2017 Paper session 31: Spotlight on the misuse of medicines Aurélie Lermenier-Jeannet.
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Edward Mbizo Sibanda, (MSc) Right to Care
Update on community-based harm reduction services in Durban
Myanmar Last Update: November 2014.
Blood borne viral hepatitis action in Wales
Mission: To reduce morbidity associated with the prevalence of TB and HIV among at-risk drug users and their contacts.
German Drug and Addiction Policy
SAFE Initiative – A Community Led Response
Employment agency market in Poland ZAGREB, July 1, 2013
HA-REACT Joint Action WP4 Testing and Linkage to care Methods:
Human Dignity and Harm Reduction
Prevention of HIV infection: How effectively are countries responding to changing epidemics in the Asia Pacific Region? 30 March 2011 Slide 1 A brief introduction.
Share your thoughts on this presentation with #IAS2019
Presentation transcript:

Reitox National Focal Point National Bureau for Drug Prevention Artur Malczewski Reitox National Focal Point National Bureau for Drug Prevention „Experiences and situation description in NPS intravenous use in Poland” 2nd European Workshop – ’Breaking the Drug Cycle’ project 19 April 2016, Budapest

Numbers of points, cities and exchanges points in 2002-2014.

Numbers of needles distributed in 2002 – 2014.

Numbers of clients in exchange programmes in 2004-2014

Numbers of needles per clients in NSP

Survey among clients of low threshold programs The study aimed to find out patterns of drug use, risky behaviours and HIV and HCV status of problem drug users. The survey included facilities which provided services for drug users such as needle and syringe exchange programmes and drop-in centres for active drug users (with needles available).

Study During a period of two weeks (from last November to first December 2008, 2010, 2012, 2014) staff members of low threshold programmes (needle and syringe exchange or drop-in centres for active drug users) held questionnaire interviews with all clients of a given programme (full sample). Contacts were made through drug users in order to exchange the injecting equipment, give advice, support or simply have a talk. The study was launched at the same time as in France. The respondents’ identities were coded in order to prevent double counting and guarantee anonymity. In the presentation there are results of the person who inject last month - 581 from 733 persons in 2008 and 246 persons from 366

Sources of the income – in 2014 r. more than one answer possible (%) N= 581 (2008); N=246 (2014)

Place of living (%) N= 581 (2008); N=246 (2014)

Percentage of clients broken down by kind of program (%) N= 581 (2008); N=246 (2014)

Level of education (%) N= 581 (2008); N=246 (2014)

Risk behaviours (%) N= 581 (2008); N=246 (2014)

HIV and HCV According to the responses of respondents 49% of respondents (48% of men and 45% women) were infected with HIV in 2008 .; In 2014. while this percentage was 47% of the respondents (52% of men and 42% women). In the case of hepatitis C percentages were much higher. In 2014. 70% were infected with HCV (69% of men and 71% women). In 2008. The percentage was higher and remained at 82% (82% of men and 80% women). N= 581 (2008); N=246 (2014)

LMP of drugs Any NPS: 60% (2014) Any opiates: 2008: 80% 2014: 48% The most problematic: Opioids: 68% (2008), 34% (2014) Amphetamine: 18% (2008) 7% (2014) Alcohol: 6% (2008), 18% (2014) NPS: 28% (2014)

Needs and recommendation for HR: More financial support for NSP to be able to provide more different service; Cooperation between all institutions; Adapting the offer to the needs of clients: not only needle exchange and syringes, drop-in should offer a wide range of intervention: (educational groups, support group, innovative ways of working, psychiatric support, therapeutic support, prevention) Shelter for current drug users or for clients of OST Taking into account changing on the drug scene: NPS

Discussion The above data on harm reduction programmes indicate that since 2002 the number of needle and syringe exchange programmes and exchange points has been falling. This situation might be caused by the following factors: opening new methadone maintenance facilities where beneficiaries of the exchange programmes enter treatment; likely fall in popularity of injecting drug use; disappearance of so-called open drug scenes (“bajzle”) e.g. in Poznań, Szczecin or Gdańsk where street workers operate; no interest in opening new exchange programmes on the part of the implementers. lack of financial resources or not willing from the cities to support harm reduction programs

http://urbandrugpolicies.com/sign-the-warsaw-declaration/

Thank you very much! artur.malczewski@kbpn.gov.pl